Overview
Phase 1 ALKS 1140 in Healthy Adults
Status:
Recruiting
Recruiting
Trial end date:
2022-10-01
2022-10-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
To evaluate the safety and tolerability of ALKS 1140 in healthy adult subjectsPhase:
Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Alkermes, Inc.
Criteria
Inclusion Criteria:- Body mass index (BMI) ≥18 and <30 kg/m2
Exclusion Criteria:
- Clinically significant illness or disease including significant cardiac,
gastrointestinal (stomach)
- Subjects who have known allergic reactions to food or medications
- Women of childbearing potential
- Any clinically significant lifetime history of suicidal behavior or ideation
(thoughts)
- Subject had lymphoma, leukemia, or any malignancy within the past 5 years